Effectiveness of Shock Wave Therapy as a Treatment for Spasticity: A Systematic Review.
extracorporeal shockwave therapy
muscle spasticity
shock wave
spasticity
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
24 Dec 2020
24 Dec 2020
Historique:
received:
02
12
2020
revised:
19
12
2020
accepted:
22
12
2020
entrez:
30
12
2020
pubmed:
31
12
2020
medline:
31
12
2020
Statut:
epublish
Résumé
The purpose of this study was to collect and analyse the available scientific evidence on the effectiveness of shock wave therapy as a treatment for spasticity. the search was performed in the following databases: PubMed, PEDro, Cochrane, Embase, and the Virtual Health Library. All publications from November 2009 to November 2019 were selected that included a sample of patients with spasticity and prior suspension of botulinum toxin, to whom shock wave therapy was applied. The methodological quality of the articles was evaluated using the Jadad scale and the pyramid of quality of scientific evidence. 25 studies involving 866 participants with spasticity were selected. The results obtained suggest that shock wave therapy appears to be effective in reducing spasticity levels irrespective of the age of the participants, the type of injury, and the tool used to measure the effect. shock wave therapy reports evidence of improvement in motor function, motor impairment, pain, and functional independence, applied independently of botulinum toxin. However, due to the heterogeneity of the protocols, there is no optimum protocol for its application, and it would be appropriate to gain more high-quality scientific evidence through primary studies.
Sections du résumé
BACKGROUND
BACKGROUND
The purpose of this study was to collect and analyse the available scientific evidence on the effectiveness of shock wave therapy as a treatment for spasticity.
METHODS
METHODS
the search was performed in the following databases: PubMed, PEDro, Cochrane, Embase, and the Virtual Health Library. All publications from November 2009 to November 2019 were selected that included a sample of patients with spasticity and prior suspension of botulinum toxin, to whom shock wave therapy was applied. The methodological quality of the articles was evaluated using the Jadad scale and the pyramid of quality of scientific evidence.
RESULTS
RESULTS
25 studies involving 866 participants with spasticity were selected. The results obtained suggest that shock wave therapy appears to be effective in reducing spasticity levels irrespective of the age of the participants, the type of injury, and the tool used to measure the effect.
CONCLUSIONS
CONCLUSIONS
shock wave therapy reports evidence of improvement in motor function, motor impairment, pain, and functional independence, applied independently of botulinum toxin. However, due to the heterogeneity of the protocols, there is no optimum protocol for its application, and it would be appropriate to gain more high-quality scientific evidence through primary studies.
Identifiants
pubmed: 33374359
pii: brainsci11010015
doi: 10.3390/brainsci11010015
pmc: PMC7823267
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Med Life. 2014;7 Spec No. 3:127-32
pubmed: 25870710
Arch Phys Med Rehabil. 2018 Nov;99(11):2143-2150
pubmed: 30392753
Control Clin Trials. 1996 Feb;17(1):1-12
pubmed: 8721797
Int J Rehabil Res. 2019 Mar;42(1):31-35
pubmed: 30211721
J Rehabil Med. 2010 Apr;42(4):339-43
pubmed: 20358168
Ultrasound Med Biol. 2016 Aug;42(8):1862-75
pubmed: 27126239
J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1546-1554
pubmed: 30935809
Chin Med J (Engl). 2013;126(24):4638-43
pubmed: 24342303
Clin Rehabil. 2020 Sep;34(9):1141-1156
pubmed: 32513019
Eur J Phys Rehabil Med. 2018 Aug;54(4):518-525
pubmed: 29072044
Ann Phys Rehabil Med. 2019 Jul;62(4):265-273
pubmed: 29042299
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD004156
pubmed: 22336799
NeuroRehabilitation. 2017;40(1):115-118
pubmed: 27814307
Ann Phys Rehabil Med. 2019 Jul;62(4):291-296
pubmed: 30219307
Dev Neurorehabil. 2021 Jan;24(1):1-7
pubmed: 31674272
J Rehabil Med. 2018 Nov 7;50(10):852-859
pubmed: 30264850
J Stroke Cerebrovasc Dis. 2017 Nov;26(11):2470-2476
pubmed: 28918085
PM R. 2019 Apr;11(4):363-371
pubmed: 30145342
Int J Rehabil Res. 2013 Sep;36(3):284-90
pubmed: 23603803
Rev Neurol. 2007 Sep 16-30;45(6):365-75
pubmed: 17899519
Medicine (Baltimore). 2016 May;95(18):e3544
pubmed: 27149465
Medicine (Baltimore). 2016 May;95(19):e3649
pubmed: 27175689
Am J Phys Med Rehabil. 2014 Dec;93(12):1065-72
pubmed: 24879552
Ann Rehabil Med. 2013 Aug;37(4):461-70
pubmed: 24020026
Ann Rehabil Med. 2015 Dec;39(6):914-21
pubmed: 26798605
Top Stroke Rehabil. 2014;21 Suppl 1:S17-24
pubmed: 24722040
J Phys Ther Sci. 2014 Oct;26(10):1641-7
pubmed: 25364134
Evid Based Complement Alternat Med. 2016;2016:4648101
pubmed: 27504139
Disabil Rehabil. 2017 Mar;39(5):483-490
pubmed: 26971745
J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):459-63
pubmed: 15774425
NeuroRehabilitation. 2011;29(4):413-9
pubmed: 22207070
NeuroRehabilitation. 2015;36(1):67-72
pubmed: 25547767
Top Stroke Rehabil. 2016 Aug;23(4):293-303
pubmed: 27077981
Evid Based Med. 2016 Aug;21(4):125-7
pubmed: 27339128
Clin Rehabil. 2016 Jun;30(6):537-48
pubmed: 26198891